Oriola Oyj Stock

Equities

OKDBV

FI0009014351

Pharmaceuticals

Market Closed - Nasdaq Helsinki 11:29:57 2024-04-24 am EDT 5-day change 1st Jan Change
1.05 EUR -0.94% Intraday chart for Oriola Oyj -0.19% -3.49%
Sales 2024 * 1.52B 1.62B Sales 2025 * 1.57B 1.68B Capitalization 196M 210M
Net income 2024 * 10M 10.7M Net income 2025 * 17M 18.2M EV / Sales 2024 * 0.13 x
Net cash position 2024 * 5.24M 5.61M Net cash position 2025 * 1.14M 1.22M EV / Sales 2025 * 0.12 x
P/E ratio 2024 *
17.3 x
P/E ratio 2025 *
10.5 x
Employees 872
Yield 2024 *
7.3%
Yield 2025 *
8.25%
Free-Float 70.11%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.94%
1 week-0.19%
Current month+3.35%
1 month+5.85%
3 months-3.49%
6 months+15.51%
Current year-3.49%
More quotes
1 week
1.03
Extreme 1.03
1.07
1 month
0.99
Extreme 0.987
1.09
Current year
0.99
Extreme 0.985
1.17
1 year
0.89
Extreme 0.888
1.48
3 years
0.89
Extreme 0.888
2.31
5 years
0.89
Extreme 0.888
2.50
10 years
0.89
Extreme 0.888
4.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 11-12-31
Director of Finance/CFO 54 22-11-30
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman 58 22-12-31
Director/Board Member 55 22-12-31
Director/Board Member 61 19-01-30
More insiders
Date Price Change Volume
24-04-24 1.05 -0.94% 30,531
24-04-23 1.06 +0.57% 81,735
24-04-22 1.054 +1.35% 78,364
24-04-19 1.04 +0.19% 120,656
24-04-18 1.038 -1.33% 68,188

Delayed Quote Nasdaq Helsinki, April 24, 2024 at 11:29 am EDT

More quotes
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
1.05 EUR
Average target price
1.175 EUR
Spread / Average Target
+11.90%
Consensus